![]() |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||
|
Produktkate gorien
AlkoholismusAllergikerAlzheimer Und ParkinsonAnalgetikaAnti-depressivaAnti-virusAntibiotikaAntikonvulsivaAntiparasitenmittelAntipilzmittelAntzündungshemmende MittelArthritisAsthmaAtemwegeAugepflegeCholesterinDiabetesDiuretikaErektionsstörungenFettsuchtFrauenmedizinGesundheit Des MannesH I VHarnweg-traktHautpflegeHerz-kreislauf-erkrankungenHypertonieKrebsMagen-darm-traktMental-psychische StörungenMigräneMuskel-relaxansNeurologische StörungenOperationenOsteoporoseVerhütungsmittel 17 May 2012 06:52:05
טבע: יעדי 2015 אופטימיים מדי? : 2015 ? ר ר ר Lexapro, Avapro Avalide ר ר , , ר . ר ר Lexapro ר ר 2.5 ר ר, ...14 May 2012 10:02:22
Teva Pharmaceuticals' Disappointing ResultsTeva Pharmaceuticals' Disappointing Results Seeking Alpha The company recently announced that it has started selling Irbesartan and irbesarten-hydrochlorothiazide tablets, a generic version of Sanofi-Aventis' high blood pressure drugs, Avapro and Avalide tablets. Teva also has exclusivity to market the ...
07 May 2012 04:33:53
Top global pharma cos post sales growth of just 3.4%, but net profit up by ...Top global pharma cos post sales growth of just 3.4%, but net profit up by ... pharmabiz.com Similarly, Aciphex Pariet of J&J , NeoRecormon Epogin of Roche and Avapro Avalide of Bristol-Myers lost blockbuster status in 2011. Besides, Lipitor and Seretide Advair, few important blockbuster products like MabThera Rituxan (Roche), ...
05 May 2012 00:19:38
Earnings Scorecard: Bristol-Myers - Analyst BlogEarnings Scorecard: Bristol-Myers - Analyst Blog NASDAQ Revenues were just shy of the Zacks Consensus Estimate of $5.26 billion, mainly due to lower sales of Plavix and Avapro Avalide . US net sales in the quarter climbed 6% to $3.5 billion. Sales in international markets increased 2% to $1.8 billion.
30 Apr 2012 15:52:22
Sanofi Beats on EPS, View Backed The Star-Ledger - NJ.com Sanofi Beats on EPS, View Backed Zacks.com Aprovel Avapro Karvea Avalide revenues declined 18.1% to 404 million due to increased generic competition. The product lost its exclusivity on March 30, 2012. Lovenox, Ambien CR and Taxotere, performed disappointingly due to generic competition in the ... Strong first quarter for Sanofi, rest of year will be tougher27 Apr 2012 09:08:23
Earnings Beat at Bristol-Myers - Analyst Blog Dividend.com Earnings Beat at Bristol-Myers - Analyst Blog NASDAQ Revenues were just shy of the Zacks Consensus Estimate of $5.26 billion, mainly due to lower sales of Plavix and Avapro Avalide . US net sales in the quarter climbed 6% to $3.5 billion. Sales in international markets increased 2% to $1.8 billion. Bristol-Myers Squibb Delivers a Solid First Quarter with Strong Operating ... Bristol-Myers 1Q profit up 12 pct. as sales rise Bristol-Myers Net Rises 12% on High Cancer Drug Sales24 Apr 2012 20:43:13
Bristol-Myers Squibb: Earnings PreviewBristol-Myers Squibb: Earnings Preview Citybizlist (press release) Net sales in the final quarter of 2011 quarter climbed 7% to $5.45 billion. Revenues were just shy of the Zacks Consensus Estimate of $5.48 billion mainly due to lower sales of Plavix and Avapro Avalide . READ FULL ARTICLE HERE.
|
|
Choose Your language:
Site-Suche:
Unsere Kundenmeinungen
Gut, ich muss mich entschuldigen . Ich dachte wirklich, dass sie mich betrügen. Aber, plötzlich überfüllte sich mein Briefkasten. Ich habe eine Bestellung am Donnerstag, den 8 Juni erhalten, und die andere am Samstag den 10 Juni. Fast 1 Monat nach ihrer ersten Bemühung, aber die Post musste der Schuldige sein. Mit diesem doppelten Vorrat, hätten Sie mir wohl auch ein paar Frauen senden müssen, damit die Medikamente nicht vorher ablaufen. Wie können wir das regeln? Was würden Sie mir empfehlen? Danke. Ich hoffe, dass nur guter Karma zu Ihnen kommt. Curt.
|
||||||||||||||||||||||||||||||||||||||||||||||||||
| Bestsellers|AGB|FAQ|Unsere Kundenmeinungen|Kontakt|Sitemap |
|
|
|
|
| |